Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

The next news from the company was supposed to be a start of Ph2 HPV+ lung cancer study by a Taiwan partner (2H2019), but the time has almost run out. So, guessing no news, no trial started. Maybe, the partner got cold feet.

Another "news" could be a termination of PSA trial and shelving the program. Merck, the potential partner for PSA program, has had lots of time to look under the hood and made no decision to jump in. Why? The only reasonable explanation is the data was not that impressive. ADXS cannot continue to pay for that trial, let alone take it to Phase 3. As the other trials before (Aim2Cerv, NEO, and etc), this PSA program is destined to wither and disappear from their corporate presentations. I'll give it a month or so. Then, the whole focus is going to be on HOT. Very binary outcome...


The Wish-list is already compiled by one of the experts.

I like the opening statement :

'All catalysts expected in the coming days:

$ADXS Who cares or gives a .... where it closed at. The point is that 7 catalysts are expected in 2nd half of 2019. Get a clue people. You want the catalysts here they are:'


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151382981